The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blinded, placebo-controlled clinical trial to determine the
efficacy and safety of a Chinese herbal medicine (Shenlingcao oral liquid) for treating long
COVID associated fatigue.
Phase:
Phase 2
Details
Lead Sponsor:
Hong Kong Baptist University
Collaborator:
China Resources Jiangzhong Pharmaceutical Co.,Ltd.